or
forgot password

    • cancer clinical trials in el paso, TX

    • S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Texas Tech University Health Sciences Center School of Medicine - El Paso
    El Paso, Texas 79905
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    The Center for Integrative Cancer Medicine
    El Paso, Texas 79902
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    El Paso Cancer Treatment Center
    El Paso, Texas 79915
    Lymphoma, T-Cell, Peripheral
    PhII ICb With/Without Erbitux in MBC Pts
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Metastatic Breast Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    The Center for Integrative Cancer Medicine
    El Paso, Texas 79902
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    The Center for Integrative Cancer Medicine
    El Paso, Texas 79902
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    El Paso Cancer Treatment Center
    El Paso, Texas 79915
    Peripheral T-cell Lymphoma
    Adj TC + Herceptin Early Stage Breast Cancer
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Metastatic Gastric or GEJ Cancer
    Pre-op Rectal ChemoRad +/- Cetuximab
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Rectal Cancer
    Phase II Sunitinib Prog Met AIPC
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Metastatic Prostate Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Androgen-independent Prostate Cancer
    Gemzar, Cisp, Sunitinib Urothelial Ca
    El Paso Cancer Treatment Center - East
    El Paso, Texas 79915
    Urothelial Cancer
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    El Paso Cancer Treatment Center - East

    Trial Locations
    El Paso Cancer Treatment Center - East
    El Paso Cancer Treatment Center - West
    Breast Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - El Paso Cancer Treatment Ctr
    El Paso, Texas 79902
    Multiple Myeloma
    BRCA Mutations in Latinas
    Texas Tech University Health Sciences Center University Health Sciences Center
    El Paso, Texas
    Breast Neoplasms
    Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
    Texas Oncology - El Paso Cancer Treatment Center Grandview
    El Paso, Texas 79915
    Breast Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Texas Oncology-El Paso
    El Paso, Texas 79915
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Texas Oncology - El Paso Cancer Treatment Center Grandview

    Trial Locations
    Texas Oncology - El Paso Cancer Treatment Center Grandview
    Texas Oncology - El Paso Cancer Treatment Center Joe Battle
    Texas Oncology - El Paso Cancer Treatment Center Gateway
    Advanced Prostate Cancer, Prostatic Neoplasms
    The Utility of Cap Colonoscopy in Increasing Adenoma Detection Rate
    Texas Tech University Health Sciences Center at El Paso
    El Paso, Texas 79905
    Adenoma
    A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
    Texas Tech University Health Science Center Dept of Texas Tech
    El Paso, Texas 79905
    Metastatic Breast Cancer HR+, HER2-
    Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD
    Texas Tech University at El Paso
    El Paso, Texas 79905
    Choledocholithiasis, Cholangiocarcinoma, Benign Stricture of Common Bile Duct
    Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
    Texas Tech Health Sciences Ctr
    El Paso, Texas 79905
    Mycobacterium Avium-Intracellulare Infection, HIV Infections
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    El Paso Cancer Treatment Center
    El Paso, Texas 79915
    Prostate Cancer, Hormone Refractory Prostate Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Center for Cancer Medicine and Blood Disorders, PA
    El Paso, Texas 79902
    Pancreatic Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    El Paso Cancer Treatment Ctr-East
    El Paso, Texas 79915
    Carcinoma, Non-Small-Cell Lung
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Center for Cancer Medicine and Blood Disorders, PA
    El Paso, Texas 79902
    Head and Neck Cancer
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Center for Cancer Medicine and Blood Disorders, PA
    El Paso, Texas 79902
    Breast Cancer
    S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Center for Cancer Medicine and Blood Disorders, PA
    El Paso, Texas 79902
    Multiple Myeloma
    Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
    UT Houston School of Public Health, El Paso Regional Campus
    El Paso, Texas 79902
    Prostate Cancer
    A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
    El Paso Cancer Treatment Center

    Trial Locations
    El Paso Cancer Treatment Center
    El Paso Cancer Treatment Center West
    Breast Cancer
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    El Paso Cancer Treatment Center--East
    El Paso, Texas 79915
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    El Paso Cancer Treatment Ctr
    El Paso, Texas 79915
    Metastatic Breast Cancer
    Cancer Genetics CD-ROM for Hispanics
    The Cancer and Chronic Disease Consortium (CCDC) of El Paso
    El Paso, Texas 79905
    Breast Cancer
    Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
    El Paso Cancer Treatment Center
    El Paso, Texas 79915
    Neuroendocrine Tumors, Carcinoid Tumor
    Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
    Texas Tech Health Science Center
    El Paso, Texas 79905
    Severe Sepsis